Man Clinic for Andrology and male infertility
Cairo, Egypt
NCT Number: NCT02414295
Klinefelter syndrome KS is caused by an additional X chromosome in males (47,XXY). Clinical findings are nonspecific during childhood; thus, the diagnosis commonly is made during adolescence or adulthood in males who have small testes with hypergonadotropic hypogonadism and gynecomastia. Virtually all men with Klinefelter syndrome are infertile.
Approximately one in 1,000 boys is born with an additional X chromosome-47,XXY, the karyotype that causes Klinefelter syndrome. This karyotype is detected at or before birth in 10 percent of affected boys, and it is found during adulthood in 25 percent of affected men. Almost all men with a 47,XXY karyotype will be infertile; Klinefelter syndrome accounts for 3 percent of male infertility.
Klinefelter syndrome is common in infertile men with oligospermia or azoospermia (5 to 10 percent).
Infertility in men with Klinefelter syndrome is caused by a precipitous drop in sperm count. If sperm are present, cryopreservation is useful for future family planning with intracytoplasmic sperm injection, and if not, testicular sperm extraction may be pursued. Although there have been multiple reports of successful fertilization by men with Klinefelter syndrome.
Mesenchymal stem cell injection in testicular tubules and intra testicular artery using surgical microscope.
The period for follow up last from three months to twelve months including semen analysis to detect sperm and hormonal profile .
Looking for future studies?
Notify Me20 year–50 year
Male
Interventional
Not applicable
Cairo, Egypt
The problem started with this kind of patinets when underwent multiple TESE without sperm.
The investigators try to inject KS patients with mesenchymal stem cells to stimulate testicular tissue for production of sperms.
before injection the investigators measure:( FSH, LH, Testosterone, Prolactin, Inhibin B, Karyotyping, Azoospermic Factor, Testicular size by ultrasound).
Three to twelf months after stem cell injection the investigators reevaluate patients by the same measure to demoenstarte any changes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aspirated bone marrow then separation for Mesenchymal stem cell
Time frame: 12 months
Semen Analysis
Time frame: 12 months
Inhibine B, FSH, LH
Man Clinic for Andrology, Male Infertility and Sexual Dysfunction
Other
Management of Azoospermic Patients With Kleinfelter Syndrome Patients With Mesenchymal Stem Cell Injection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01918280
Azoospermia, Chromosome Disorders
Bordeaux, France
View Trial DetailsNCT01206270
Chromosome Disorders, Congenital Abnormalities
Rome, Lazio, Italy
View Trial DetailsNCT05586802
Chromosome Disorders, Congenital Abnormalities
Lausanne, Switzerland
View Trial DetailsNCT03325647
Chromosome Disorders, Congenital Abnormalities
Aurora, Colorado, United States
View Trial Details